PURPOSE: To determine the impact of applying an age cutoff to tumor-based Lynch syndrome (LS) screening, specifically focusing on changes in relative effectiveness, efficiency, and cost. The project was undertaken to answer questions about implementation of the LS screening program in an integrated health care delivery system. PATIENTS AND METHODS: Clinical data extracted from an internal cancer registry, previous modeling efforts, published literature, and gray data were used to populate decision models designed to answer questions about the impact of age cutoffs in LS screening. Patients with colorectal cancer (CRC) were stratified at 10-year intervals from ages 50 to 80 years and compared with no age cutoff. Outcomes are reported for a cohort of 325 patients screened and includes total cost to screen, LS cases present in the cutoff category, number of LS cases expected to be identified by screening, cost per LS case detected, and total number and percentage of LS cases missed. CONCLUSION: Applying an age cutoff to an LS screening program has considerable potential for decreasing total screening costs and increasing efficiency, but at a loss of effectiveness. Imposing an age cutoff of 50 years reduces the cost of the screening program to 16% of a program with no age cutoff, but at the expense of missing more than half of the cases. Failure to identify LS cases is magnified by a cascade effect in family members. The results of this analysis influenced the final policy in our system.
PURPOSE: To determine the impact of applying an age cutoff to tumor-based Lynch syndrome (LS) screening, specifically focusing on changes in relative effectiveness, efficiency, and cost. The project was undertaken to answer questions about implementation of the LS screening program in an integrated health care delivery system. PATIENTS AND METHODS: Clinical data extracted from an internal cancer registry, previous modeling efforts, published literature, and gray data were used to populate decision models designed to answer questions about the impact of age cutoffs in LS screening. Patients with colorectal cancer (CRC) were stratified at 10-year intervals from ages 50 to 80 years and compared with no age cutoff. Outcomes are reported for a cohort of 325 patients screened and includes total cost to screen, LS cases present in the cutoff category, number of LS cases expected to be identified by screening, cost per LS case detected, and total number and percentage of LS cases missed. CONCLUSION: Applying an age cutoff to an LS screening program has considerable potential for decreasing total screening costs and increasing efficiency, but at a loss of effectiveness. Imposing an age cutoff of 50 years reduces the cost of the screening program to 16% of a program with no age cutoff, but at the expense of missing more than half of the cases. Failure to identify LS cases is magnified by a cascade effect in family members. The results of this analysis influenced the final policy in our system.
Authors: Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Mark Clendenning; Kaisa Sotamaa; Thomas Prior; Judith A Westman; Jenny Panescu; Dan Fix; Janet Lockman; Jennifer LaJeunesse; Ilene Comeras; Albert de la Chapelle Journal: J Clin Oncol Date: 2008-09-22 Impact factor: 44.544
Authors: Heather Hampel; Julie A Stephens; Eero Pukkala; Risto Sankila; Lauri A Aaltonen; Jukka-Pekka Mecklin; Albert de la Chapelle Journal: Gastroenterology Date: 2005-08 Impact factor: 22.682
Authors: Noralane M Lindor; Gloria M Petersen; Donald W Hadley; Anita Y Kinney; Susan Miesfeldt; Karen H Lu; Patrick Lynch; Wylie Burke; Nancy Press Journal: JAMA Date: 2006-09-27 Impact factor: 56.272
Authors: Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Hidewaki Nakagawa; Kaisa Sotamaa; Thomas W Prior; Judith Westman; Jenny Panescu; Dan Fix; Janet Lockman; Ilene Comeras; Albert de la Chapelle Journal: N Engl J Med Date: 2005-05-05 Impact factor: 91.245
Authors: Monica M Bertagnolli; Donna Niedzwiecki; Carolyn C Compton; Hejin P Hahn; Margaret Hall; Beatrice Damas; Scott D Jewell; Robert J Mayer; Richard M Goldberg; Leonard B Saltz; Robert S Warren; Mark Redston Journal: J Clin Oncol Date: 2009-03-09 Impact factor: 44.544
Authors: Glenn E Palomaki; Monica R McClain; Stephanie Melillo; Heather L Hampel; Stephen N Thibodeau Journal: Genet Med Date: 2009-01 Impact factor: 8.822
Authors: Cecelia A Bellcross; Sara R Bedrosian; Elvan Daniels; Debra Duquette; Heather Hampel; Kory Jasperson; Djenaba A Joseph; Celia Kaye; Ira Lubin; Laurence J Meyer; Michele Reyes; Maren T Scheuner; Sheri D Schully; Leigha Senter; Sherri L Stewart; Jeanette St Pierre; Judith Westman; Paul Wise; Vincent W Yang; Muin J Khoury Journal: Genet Med Date: 2011-10-27 Impact factor: 8.822
Authors: Carlos J Gallego; Brian H Shirts; Caroline S Bennette; Greg Guzauskas; Laura M Amendola; Martha Horike-Pyne; Fuki M Hisama; Colin C Pritchard; William M Grady; Wylie Burke; Gail P Jarvik; David L Veenstra Journal: J Clin Oncol Date: 2015-05-04 Impact factor: 44.544
Authors: Celine H M Leenen; Anne Goverde; Esther W de Bekker-Grob; Anja Wagner; Margot G F van Lier; Manon C W Spaander; Marco J Bruno; Carli M Tops; Ans M W van den Ouweland; Hendrikus J Dubbink; Ernst J Kuipers; Winand N M Dinjens; Monique E van Leerdam; Ewout W Steyerberg Journal: Genet Med Date: 2016-03-03 Impact factor: 8.822
Authors: Alanna Kulchak Rahm; Deborah Cragun; Jessica Ezzell Hunter; Mara M Epstein; Jan Lowery; Christine Y Lu; Pamala A Pawloski; Ravi N Sharaf; Su-Ying Liang; Andrea N Burnett-Hartman; James M Gudgeon; Jing Hao; Susan Snyder; Radhika Gogoi; Ilene Ladd; Marc S Williams Journal: BMC Health Serv Res Date: 2018-10-30 Impact factor: 2.655
Authors: Dayna R Cenin; Steffie K Naber; Iris Lansdorp-Vogelaar; Mark A Jenkins; Daniel D Buchanan; David B Preen; Hooi C Ee; Peter O'Leary Journal: J Gastroenterol Hepatol Date: 2018-05-17 Impact factor: 4.029
Authors: Jing Hao; Dina Hassen; James M Gudgeon; Susan R Snyder; Heather Hampel; Marc S Williams; Ravi N Sharaf; Christine Y Lu; Janet L Williams; Victoria Schlieder; Alanna Kulchak Rahm Journal: J Pers Med Date: 2021-12-02
Authors: Deborah Cragun; Rita D DeBate; Susan T Vadaparampil; Julie Baldwin; Heather Hampel; Tuya Pal Journal: Genet Med Date: 2014-03-20 Impact factor: 8.822